, NIH Consensus Development Panel on Osteoporosis, JAMA, vol.285, pp.785-95, 2001.

M. E. Tinetti, M. Speechley, and S. F. Ginter, Risk factors for falls among elderly persons living in the community, N Engl J Med, vol.319, pp.1701-1708, 1988.

A. J. Milat, W. L. Watson, C. Monger, M. Barr, M. Giffin et al., Prevalence, circumstances and consequences of falls among community-dwelling older people : results of the 2009 NSW Falls Prevention Baseline Survey, vol.22, pp.43-51, 2011.

M. Maravic, L. Bihan, C. Landais, P. Fardellone, and P. , Incidence and cost of osteoporotic fractures in France during 2001. A methodological approach by the national hospital database, Osteoporos Int, vol.16, pp.1475-80, 2005.

K. Briot, M. Maravic, and C. Roux, Changes in number and incidence of hip fractures over 12 years in France, Bone, vol.81, pp.131-138, 2015.

T. Thomas, P. Gabach, and D. Buchon, Évaluation de la prise en charge avant et après hospitalisation pour fracture de fragilité en France à partir des dossiers de la SNIIRAM

S. Congrès, , 2015.

D. H. Solomon, S. S. Johnston, N. N. Boytsov, D. Mcmorrow, J. M. Lane et al., Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011, J Bone Miner Res, vol.29, pp.1929-1966, 2014.
DOI : 10.1002/jbmr.2202
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.2202

E. S. Leblanc, T. A. Hillier, and K. L. Pedula, Hip fracture and increased short-term but not long-term mortality in healthy older women, Arch Intern Med, vol.171, pp.1831-1838, 2011.

. Melton-lj-3rd, S. J. Achenbach, E. J. Atkinson, T. M. Therneau, and S. Amin, Long-term mortality following fractures at different skeletal sites : a population-based cohort study, Osteoporos Int, vol.24, pp.1689-1698, 2013.

D. Bliuc, N. D. Nguyen, and V. E. Milch, Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women, JAMA, vol.301, pp.513-534, 2009.

J. Clinton, A. Franta, N. L. Polissar, B. Neradilek, D. Mounce et al.,

. Matsen, Proximal humeral fracture as a risk factor for subsequent hip fractures, J Bone Joint Surg Am, vol.91, pp.503-514, 2009.

D. Bliuc, T. V. Nguyen, J. A. Eisman, and J. R. Center, The impact of nonhip nonvertebral fractures in elderly women and men, J Clin Endocrinol Metab, vol.99, pp.415-438, 2014.

M. T. Cuddihy, S. E. Gabriel, C. S. Crowson, W. M. O'fallon, and L. J. Melton, Forearm fractures as predictors of subsequent osteoporotic fractures, Osteoporos Int, vol.9, pp.469-75, 1999.

R. Lindsay, S. L. Silverman, and C. Cooper,

T. A. Van-geel, S. Van-helden, P. P. Geusens, B. Winkens, and G. J. Dinant, Clinical subsequent fractures cluster in time after first fractures, Ann Rheum Dis, vol.68, pp.99-102, 2009.

T. A. Van-geel, N. D. Nguyen, and P. P. Geusens, Development of a simple prognostic nomogram for individualising 5-year and 10-year absolute risks of fracture : a populationbased prospective study among postmenopausal women, Ann Rheum Dis, vol.70, pp.92-99, 2011.

M. Bonafede, N. Shi, R. Barron, X. Li, D. B. Crittenden et al., Predicting imminent risk for fracture in patients aged 50 or older with osteoporosis using US claims data, Arch Osteoporos, vol.11, p.26, 2016.

K. M. Huntjens, T. A. Van-geel, and S. Van-helden, The role of the combination of bone and fall related risk factors on short-term subsequent fracture risk and mortality, BMC Musculoskelet Disord, vol.14, p.121, 2013.

A. Amouzougan, L. Lafaie, H. Marotte, D. D?nari?, and T. Thomas, High prevalence of dementia in women with osteoporosis, Joint Bone Spine, vol.84, pp.611-614, 2017.
DOI : 10.1016/j.jbspin.2016.08.002

M. Laroche, V. Pécourneau, H. Blain, and V. Breuil,

I. Osteoporosis and . Disease, Joint Bone Spine, vol.84, pp.427-459, 2017.

D. M. Black, N. K. Arden, L. Palermo, J. Pearson, and S. R. Cummings, Prevalent vertebral deformities predict hip fractures and new vertebral deformities but nop wrist fractures, J Bone Miner Res, vol.5, pp.821-829, 1999.
DOI : 10.1359/jbmr.1999.14.5.821

C. M. Klotzbuecher, P. D. Ross, P. B. Landsman, T. A. Abbott, and M. Berger, Patients with prior fractures have an increased risk of future fractures : a summary of the literature and statistical synthesis, J Bone Miner Res, vol.15, pp.721-760, 2000.

L. M. Giangregorio and W. D. Leslie,

, Time since prior fracture is a risk modifier for 10-year osteoporotic fractures, J Bone Miner Res, vol.25, pp.1400-1405, 2010.

, Assessment of fracture risk and its application to screening for postmenopausal osteoporosis : report of a WHO study group, pp.1-29, 1994.

E. M. Lewiecki, N. B. Watts, and M. R. Mcclung, Official position of the International Society for Clinical Densitometry, J Clin Endocrinol Metab, vol.89, pp.3651-3656, 2004.

J. A. Kanis, E. V. Mccloskey, H. Johansson, A. Oden, . Melton-lj-3rd et al., A reference standard for the description of osteoporosis, Bone, vol.42, pp.467-75, 2008.

M. A. Paggiosi, C. C. Gluer, and C. Roux, International variation in proximal femur bone mineral density, Osteoporos Int, vol.22, pp.721-730, 2011.
DOI : 10.1016/j.bone.2009.03.088

D. Marshall, O. Johnell, and H. Wedel, Metanalysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures, BMJ, vol.312, pp.1254-1263, 1996.

S. Fujiwara, F. Kasagi, N. Masunari, K. Naito, G. Suzuki et al., Fracture prediction from bone mineral density in Japanese men and women, J Bone Miner Res, vol.18, pp.1547-53, 2003.

E. Sornay-rendu, F. Munoz, P. Garnero, F. Duboeuf, and P. D. Delmas, Identification of osteopenic women at high risk of fracture : the OFELY study, J Bone Miner Res, vol.20, pp.1813-1822, 2005.

O. Johnell, J. A. Kanis, and A. Oden, Predictive value of BMD for hip and other fractures, J Bone Miner Res, vol.20, pp.1185-94, 2005.

D. W. Bates and D. M. Black, Cummings SR Clinical use of bone densitometry : clinical applications, JAMA, vol.288, pp.1898-900, 2002.

S. R. Cummings, D. M. Black, and M. C. Nevitt, Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group, Lancet, vol.341, pp.72-77, 1993.

S. Sc, M. Van-der-klift, A. E. Weel, C. E. De-laet, H. Burger et al., Fracture incidence and association with bone mineral density in elderly men and women : the Rotterdam Study, Bone, vol.34, pp.195-202, 2004.

E. S. Siris, Y. T. Chen, and T. A. Abbott, Bone mineral density threshold for pharmacological intervention to prevent fractures, Arch Intern Med, vol.164, pp.1108-1120, 2004.
DOI : 10.1001/archinte.164.10.1108
URL : https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/217016/ioi30223.pdf

S. A. Wainwright, L. M. Marshall, and K. E. Ensrud, Hip fracture in women without osteoporosis, J Clin Endocrinol Metab, vol.90, pp.2787-93, 2005.

A. V. Schwartz, E. Vittinghoff, and D. C. Bauer, Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes, JAMA, vol.305, pp.2184-92, 2011.

M. O. Premaor, K. Ensrud, L. Lui, R. A. Parker, J. Cauley et al., Study of Osteoporotic Fractures Risk factors for nonvertebral fracture in obese older

R. M. Neer, C. D. Arnaud, and J. R. Zanchetta, Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis, N Engl J Med, vol.344, pp.1434-1475, 2001.

S. R. Cummings, S. Martin, J. Mcclung, and M. R. , Denosumab for prevention of fractures in postmenopausal women with osteoporosis, N Engl J Med, vol.361, pp.756-65, 2009.

D. B. Karpf, D. R. Shapiro, and E. Seeman, Prevention of non vertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study groups, JAMA, vol.277, pp.1159-64, 1997.
DOI : 10.1001/jama.1997.03540380073035

M. R. Clung, P. Gensens, and P. D. Miller, Effect of risedronate on the risk of hip fracture in elderly women, N Engl J Med, vol.344, pp.333-340, 2001.

S. E. Papapoulos, Q. Sa, and U. A. Liberman, Metaanalysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women, Osteoporos int, vol.16, pp.468-74, 2005.

K. Ganda, M. Puech, and J. S. Chen, Models of care for the secondary prevention of osteoporotic fractures : a systematic review and meta-analysis, Osteoporos Int, vol.24, pp.393-406, 2013.

K. M. Huntjens, T. A. Van-geel, and J. P. Van-den-bergh, Fracture liaison service : impact on subsequent nonv ertebral fracture incidence and mortality, J Bone Joint Surg Am, vol.96, p.29, 2014.

H. Blain, Y. Rolland, and O. Beauchet, Usefulness of bone density measurement in fallers, Joint Bone Spine, vol.81, pp.403-411, 2014.
DOI : 10.1016/j.jbspin.2014.01.020
URL : https://hal.archives-ouvertes.fr/hal-01128189

L. D. Gillespie, M. C. Robertson, and W. J. Gillespie, Interventions for preventing falls in older people living in the community, Cochrane Database Syst Rev, issue.9, p.7146, 2012.

F. El-khoury, B. Cassou, M. A. Charles, and P. Dargent-molina, The effect of fall prevention exercise programmes on fall induced injuries in community dwelling older adults : systematic review and meta-analysis of randomised controlled trials, BMJ, vol.347, p.6234, 2013.

F. El-khoury, B. Cassou, A. Latouche, P. Aegerter, M. A. Charles et al., Effectiveness of two year balance training programme on prevention of fall induced injuries in at risk women aged 75-85 living in community : Ossébo randomised controlled trial, BMJ, vol.351, p.3830, 2015.

T. M. Gill, M. Pahor, and J. M. Guralnik, Effect of structured physical activity on prevention of serious fall injuries in adults aged 70-89 : randomized clinical trial (LIFE Study), BMJ, vol.352, p.245, 2016.

M. J. Bolland, P. A. Barber, and R. N. Doughty, Vascular events in healthy older women receiving calcium supplementation : randomised controlled trial, BMJ, vol.336, pp.262-268, 2008.
DOI : 10.1136/bmj.39440.525752.be
URL : https://www.bmj.com/content/336/7638/262.full.pdf

M. Austin, Y. C. Yang, and E. Vittinghoff, Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures, J Bone Miner Res, vol.27, pp.687-93, 2012.

D. C. Bauer, A. Schwartz, and L. Palermo, Fracture prediction after discontinuation of 4 to 5 years of alendronate therapy : the FLEX study, JAMA Intern Med, vol.174, pp.1126-1160, 2014.

F. Cosman, J. A. Cauley, and R. Eastell, Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid : when is it reasonable to discontinue treatment?, J Clin Endocrinol Metab, vol.99, pp.4546-54, 2014.

S. Ferrari, J. D. Adachi, and K. Lippuner, Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years, Osteoporos Int, vol.26, pp.2763-71, 2015.

A. A. Khan, A. Morrison, and D. A. Hanley, Diagnosis and management of osteonecrosis of the jaw : a systematic review and international consensus, J Bone Miner Res, vol.30, pp.3-23, 2015.

E. Shane, D. Burr, and B. Abrahamsen, Atypical subtrochanteric and diaphyseal femoral fractures : second report of a task force of the, J Bone Miner Res, vol.29, pp.1-23, 2014.

L. Gedmintas, D. H. Solomon, and S. C. Kim, Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture : a systematic review and meta-analysis, J Bone Miner Res, vol.28, pp.1729-1766, 2013.
DOI : 10.1002/jbmr.1893
URL : http://europepmc.org/articles/pmc3713078?pdf=render

C. R. Cardwell, C. C. Abnet, M. M. Cantwell, and L. J. Murray, Exposure to oral bisphosphonates and risk of esophageal cancer, JAMA, vol.304, pp.657-63, 2010.

H. G. Bone, D. Hosking, and J. P. Devogelaer, Ten years' experience with alendronate for osteoporosis in postmenopausal women, N Engl J Med, vol.350, pp.1189-99, 2004.
DOI : 10.1056/nejmoa030897

D. M. Black, A. V. Schwartz, K. E. Ensrud, J. A. Cauley, S. Levis et al.,

. Flex-research-group, Effects of continuing or stopping alendronate after 5 years of treatment : the Fracture Intervention Trial Long-term Extension (FLEX) : a randomized trial

, JAMA, vol.296, pp.2927-2965, 2006.

D. D. Mellström, O. H. Sörensen, S. Goemaere, C. Roux, T. D. Johnson et al., Seven years of treatment with risedronate in women with postmenopausal osteoporosis, Calcif Tissue Int, vol.75, pp.462-470, 2004.

S. Martino, J. A. Cauley, and E. Barrett-connor, Continuing outcomes relevant to Evista

D. M. Black, I. R. Reid, and J. A. Cauley, The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis : a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT), J Bone Miner Res, 2015.

H. G. Bone, R. B. Wagman, and M. L. Brandi, 10 years of denosumab treatment in postmenopausal women with osteoporosis : results from the phase 3 randomised FREEDOM trial and open-label extension, Lancet Diabetes Endocrinol, pp.30138-30147, 2017.

R. Lindsay, W. H. Scheele, and R. Neer, Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis, Arch Intern Med, vol.164, pp.2024-2054, 2004.

R. Prince, A. Sipos, A. Hossain, and U. Syversen, Sustained non vertebral fragility fracture risk reduction after discontinuation of teriparatide treatment, J Bone Miner Res, vol.20, pp.1507-1520, 2005.
DOI : 10.1359/jbmr.050501

B. Z. Leder, J. N. Tsai, A. V. Uihlein, P. M. Wallace, H. Lee et al.,

, Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study) : extension of a randomised controlled trial, Lancet, vol.386, pp.1147-55, 2015.

N. Freemantle, S. Satram-hoang, and E. T. Tang, Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study : a 24-month, randomized, crossover comparison with alendronate in postmenopausal women, Osteoporos Int, vol.23, pp.317-343, 2012.

S. R. Cummings, S. Ferrari, and R. Eastell, Vertebral Fractures After Discontinuation of Denosumab : A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension, J Bone Miner Res, vol.33, pp.190-198, 2018.

D. L. Kendler, C. Roux, and C. L. Benhamou, Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy, J Bone Miner Res, vol.25, pp.72-81, 2010.

C. Roux, L. C. Hofbauer, and P. R. Ho, Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy : efficacy and safety results from a randomized open-label study, Bone, vol.58, pp.48-54, 2014.

P. D. Miller, N. Pannacciulli, and J. P. Brown, Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates, J Clin Endocrinol Metab, vol.101, pp.3163-70, 2016.

M. Mcclung, R. Recker, and P. Miller, Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate, Bone, vol.41, pp.122-130, 2007.